Investor Presentation • May 14, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

© 2025 De Nora


Paolo Dellachà CEO

Luca Oglialoro CFO

Chiara Locati Head of IR & ESG


2024 Business and Financial Achievements
2024 Financial Results Review
Sustainability Journey - Update
Final Remarks
Q&A

GROWTH AND PROFITABILITY…
NET CASH POSITION €27.8m

• Solid Balance Sheet, Capital Allocation focuses on external and internal growth opportunities
• Water Positive Momentum continues with Backlog up by 17% vs Dec 2024
• Energy Transition: ~200 MW realized, €17.7m revenues in line with scheduling
• Electrode and Water Techs combined Revenues +12.4% YoY
• Adj. EBITDA margin: Electrodes Techs 22.5%, Water Techs 22.7%
• +6% YoY Revenues (+4.8% @ constant fx)
• +8.2% YoY Adj EBITDA1
PRODUCTION AND R&D FOOTPRINT
• R&D Aristocrat: New Innovation Center inaugurated in Mentor, Ohio • Keep developing the Italian Gigafactory
ESG JOURNEY NEVER STOPS


€200.4 m +6.0% YoY +4.8% @ constant fx
2.8% +180 bps
€39.4m +8.2% YoY 19.7% Adj Ebitda margin
€18.9 m +1.7% YoY 9.4% Net margin
€27.8m €118€ €9.4 m @31 March 2024
€106.8 m Revenues +15.2% YoY 22.5% Adj.Ebitda margin
€17.7 m Revenues €26.6m in Q1 2024 -€1.8m Adj.Ebitda
€75.9 m Revenues +8.7% YoY 22.7% Adj.Ebitda margin
€556.2 m Broadly in line with 31 Dec'24 €191 m Order Intake


Q1 2025 ORDERS BY GEO

BACKLOG Good Start to the Year with order and revenue growth

O r d e r i n t a k e k e e p s g r o w i n g a n d i m p r o v i n g r e v e n u e g r o w t h v i s i b i l i t y


Positive Momentum Continues…





Municipal | Wastewater Treatment Plant Water Treatment capacity: 400k m3 /d New installation
SORB® Filtration

F l a g s h i p O r d e r s a c h i e v e d i n Q 1 2 0 2 5 2 / 2 W A T E R T E C H N O L O G I E S B U S I N E S S


Seaclor® System

Industrial | Oil & Gas Water Treatment capacity: 28k m3 /h New installation

Capital Control ® Municipal | Drinking Water Water Production capacity: 35k m3 /h New installation

Chlorine Dioxide Generator
PERKASIE City, Pennsylvania US SORB ® Municipal | Water Treatment Removal of PFAS To be delivered by Q3 2025

SORB® Filtration





… H o w c o u n t r i e s a r e c r e a t i n g a s u s t a i n a b l e H 2 m a r k e t
• €1.3bn for 2.3 GW green H2 project
• €3bn for green H2 production and decarbonize industrial processes
• €4bn for clean H2 production, 4.5 GW by 2030
• 15y CfD style subsidy to support grey to green transition
• \$1.6bn for green H2 production
12 © 2025 De Nora • New Gov to support clean H2 production
processes • \$10bn in green H2 projects through its Public Investment Fund by 2030
• Develop a first-world commercial corridor to export liquid H2 to EU by 2029 - Auctions to allocate up to 300 km2for green H2 project development.
• \$32.8bn for green H2 production with internal investors
• \$7bn for green H2 production for 1mtpa ammonia

S t e a d y P i p e l i n e , w h i l e n e w F I D s a r e t a k i n g l o n g e r t h a n e x p e c t e d

YEARS OF
DEPLOYMENT
| o/w ACTIVELY PURSUED |
11 GW | 18 GW | 25 GW |
|---|---|---|---|
| € BN | 1.0 | 1.7 | 2.4 |
| Actively Pursued | |||
| Avg Size | 240 MW | 550 MW | 600 MW |
92% 2025 8% 2026+
*Actively pursued projects in which our partners, and especially those with whom we are closely cooperating, have been having active interactions
13 © 2025 De Nora
TOTAL
PIPELINE
€ BN


In addition to the existing 5 R&D Labs in US, Ita, and Japan
Focus:
Innovation Center Mentor - US
2024 Business and Financial Achievements
Sustainability Journey - Update
Final Remarks
Q&A


• Revenue trend reflects backlog timeline mainly related to Neom and Stegra projects. FY guidance confirmed
Electrode Technologies Energy Transition

Water Technologies


• COGS – Incidence on Revenues broadly aligned with Q1'24
• G&A and Corporate costs increased mainly due to corporate structure enhancement and some inflationary effects.
• R&D: slight reduction driven by fixed cost efficiencies, despite work force increase
*Net of non-recurring costs (income): 1) COGS: € 1.6m in Q1 25; € 0.2m in Q1 24; 2) SG&A and R&D: € 0.3m in 1Q 25; € 0.5m in Q1 24




+47% Adj. EBITDA underpinned both by:
Profitability trend reflects:



Electrode Technologies Slightly below 2024

Technologies Mid Single-Digit Growth

High Single-Digit Growth
LOW SINGLE-DIGIT GROWTH ADJ. EBITDA MARGIN
Excluding non-recurring Gigafactory net costs*


2024 Business and Financial Achievements
2024 Financial Results Review
Sustainability Journey - Update
Final Remarks
Q&A


Click here to download our 2024 executive summary

Six-month training program by UN Global Compact

2024 Business and Financial Achievements
2024 Financial Results Review
Sustainability Journey - Update
Q&A



Strong start to the year: +12% core business revenues driven by Electrode Techs and Pools

Healthy profitability supported by volumes and production efficiencies. Our Solid Financial Structure is confirmed.
Positive Water momentum continues, with backlog growing on strong order intake. Revenues and profitability boost the consolidated results.

Well positioned in a volatile and complex macroeconomic scenario: Guidance 2025 confirmed

The core business outlook remains resilient while awaiting the recovery of a new Energy Transition market

Keep Pursuing our growth strategy which includes: strategic alliances, technology development and potential external growth, will drive performance




Jun. 17 Ceo Conference, Milano – Mediobanca

[email protected] Investor Relations | Overview | De Nora ph: +39 02 2129 2124
| O DE NORA | ||
|---|---|---|
| ----------- | -- | -- |
| (€m) | Q1 2023 | Q2 2023 | H1 2023 | Q3 2023 | 9M 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | H1 2024 | Q3 2024 | 9M 2024 | Q4 2024 | FY 2024 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.9 | 203.5 | 420.4 | 209.4 | 629.8 | 226.6 | 856.4 | 189.1 | 211.2 | 400.3 | 200.9 | 601.2 | 261.4 | 862.6 | 200.4 |
| YoY Growth (%) | 8.6% | -4.8% | 2.4% | 1.6% | 2.1% | -4.1% | 0.4% | -12.8% | 3.8% | -4.8% | -4.1% | -4.5% | 15.4% | 0.7% | 6.0% |
| Royalties and commissions | (2.2) | (2.7) | (4.9) | (2.3) | (7.2) | (2.3) | (9.5) | (2.0) | (2.5) | (4.5) | (1.9) | (6.4) | (2.9) | (9.3) | (1.8) |
| Cost of goods sold | (138.4) | (131.3) | (269.7) | (140.0) | (409.7) | (146.0) | (555.7) | (120.7) | (140.6) | (261.3) | (137.4) | (398.7) | (176.2) | (574.9) | (129.5) |
| Selling expenses | (7.5) | (7.5) | (15.0) | (7.5) | (22.5) | (7.6) | (30.1) | (8.1) | (7.5) | (15.6) | (7.6) | (23.2) | (8.6) | (31.8) | (8.0) |
| G&A expenses | (11.7) | (12.6) | (24.3) | (13.4) | (37.7) | (14.2) | (51.9) | (12.0) | (12.5) | (24.5) | (12.2) | (36.7) | (13.9) | (50.6) | (12.8) |
| R&D expenses | (3.5) | (3.3) | (6.8) | (3.4) | (10.2) | (5.8) | (16.0) | (4.0) | (4.0) | (8.0) | (4.1) | (12.1) | (2.7) | (14.8) | (3.0) |
| Other operating income (expenses) | 0.5 | (0.9) | (0.4) | 0.9 | 0.5 | 14.5 | 15.0 | 0.9 | 6.0 | 6.9 | 0.6 | 7.5 | (1.2) | 6.3 | (0.4) |
| Corporate costs | (7.2) | (9.0) | (16.2) | (7.2) | (23.4) | (8.4) | (31.8) | (7.5) | (9.2) | (16.7) | (8.1) | (24.8) | (10.9) | (35.7) | (8.9) |
| EBITDA | 46.9 | 36.2 | 83.1 | 36.5 | 119.6 | 56.8 | 176.4 | 35.7 | 40.9 | 76.6 | 30.2 | 106.8 | 45.0 | 151.8 | 36.0 |
| Margin (%) | 21.6% | 17.8% | 19.8% | 17.4% | 19.0% | 25.1% | 20.6% | 18.9% | 19.4% | 19.1% | 15.0% | 17.8% | 17.2% | 17.6% | 18.0% |
| Depreciation and amortization | (7.2) | (7.2) | (14.4) | (7.4) | (21.8) | (8.8) | (30.6) | (8.2) | (8.0) | (16.2) | (8.2) | (24.4) | (9.9) | (34.3) | (9.1) |
| Impairment | - | (1.3) | (1.3) | - | (1.3) | (7.6) | (8.9) | - | - | - | - | - | (0.9) | (0.9) | - |
| EBIT | 39.7 | 27.7 | 67.4 | 29.1 | 96.5 | 40.4 | 136.9 | 27.5 | 32.9 | 60.4 | 22.0 | 82.4 | 34.2 | 116.6 | 26.9 |
| Margin (%) | 18.3% | 13.6% | 16.0% | 13.9% | 15.3% | 17.8% | 16.0% | 14.5% | 15.6% | 15.1% | 11.0% | 13.7% | 13.1% | 13.5% | 13.4% |
| Share of profit of equity-accounted investees | - | 1.5 | 1.5 | 2.1 | 3.6 | 1.8 | 5.4 | - | (1.9) | (1.9) | 1.5 | (0.4) | 5.0 | 4.6 | - |
| Net Finance income / (expenses) | (3.9) | (0.6) | (4.5) | 131.4 | 126.9 | (4.0) | 122.9 | (0.3) | (1.9) | (2.2) | (4.3) | (6.5) | 3.1 | (3.4) | (2.2) |
| Profit before tax | 35.8 | 28.6 | 64.4 | 162.6 | 227.0 | 38.2 | 265.2 | 27.2 | 29.1 | 56.3 | 19.2 | 75.5 | 42.3 | 117.8 | 24.7 |
| Income taxes | (10.7) | (7.0) | (17.7) | (10.7) | (28.4) | (5.8) | (34.2) | (9.2) | (7.1) | (16.3) | (6.7) | (23.0) | (11.5) | (34.5) | (8.7) |
| Net Result | 25.1 | 21.6 | 46.7 | 151.9 | 198.6 | 32.4 | 231.0 | 18.0 | 22.0 | 40.0 | 12.5 | 52.5 | 30.8 | 83.3 | 16.0 |
Starting from H1'24, De Nora, to better represent the operational profitability of the Group, decided to change its EBITDA definition, including in the EBITDA and Adj EBITDA, Accrual, Utilization and Release of Provisions for Risks and Charges, previously classified below the EBITDA. The related Q1 2024 figures have been restated accordingly.

| (€m) | '23 Q1 |
'23 Q2 |
'23 Q3 |
'23 Q4 |
'24 Q1 |
'24 Q2 |
'24 Q3 |
'24 Q4 |
'25 Q1 |
'25 Q1 vs |
|---|---|---|---|---|---|---|---|---|---|---|
| '24 Q1 |
||||||||||
| REVENUES | 216 9 |
203 5 |
209 4 |
226 6 |
189 1 |
211 2 |
200 9 |
261 4 |
200 4 |
6 0% |
| Electrode Technologies |
118 9 |
112 8 |
121 0 |
111 5 |
92 7 |
112 1 |
117 5 |
131 | 106 8 |
2% 15 |
| Energy Transition |
26 6 |
20 7 |
21 3 |
33 6 |
26 6 |
25 7 |
17 9 |
35 0 |
17 7 |
-33 5% |
| Technologies Water |
71 4 |
70 0 |
67 1 |
81 5 |
69 8 |
73 4 |
65 5 |
95 4 |
75 9 |
7% 8 |
| Adj EBITDA |
47 0 |
37 4 |
37 6 |
50 7 |
36 4 |
38 9 |
32 0 |
50 1 |
39 4 |
2% 8 |
| Adj EBITDA Margin |
21 7% |
18 4% |
18 0% |
22 4% |
19 2% |
18 4% |
15 9% |
19 2% |
19 7% |
|
| Electrode Technologies |
31 0 |
29 7 |
28 1 |
29 8 |
25 3 |
23 9 |
25 3 |
27 0 |
24 0 |
1% -5 |
| Ebitda Adj Margin |
26 1% |
26 3% |
23 2% |
26 7% |
27 3% |
21 3% |
21 5% |
20 6% |
22 5% |
|
| Energy Transition |
5 0 |
0 6 |
1 5 |
4 8 |
(0 6) |
4 0 |
(3 5) |
5 7 |
(1 8) |
0% 200 |
| Ebitda Adj Margin |
18 8% |
2 9% |
0% 7 |
14 3% |
-2 3% |
15 6% |
-19 6% |
16 3% |
-10 2% |
|
| Technologies Water |
11 0 |
7 1 |
8 0 |
16 1 |
11 7 |
11 0 |
10 2 |
17 4 |
17 2 |
47 0% |
| Ebitda Adj Margin |
15 4% |
10 1% |
11 9% |
19 8% |
16 8% |
15 0% |
15 6% |
18 2% |
22 7% |
Starting from H1'24 De Nora, to better represent the operational profitability of the Group, decided to change its EBITDA definition, including in the EBITDA and Adj EBITDA, Accrual, Utilization and Release of Provisions for Risks and Charges, previously classified below the EBITDA. The related H1 2023 figures have been restated accordingly.

| (€m) | Q1 2024 |
Q1 2025 |
|---|---|---|
| Sales | 189 1 |
200 4 |
| EBITDA | 35 7 |
36 0 |
| (%) Margin |
18 9% |
18 0% |
| (labor legal expenses) Termination costs + |
0 4 |
0 1 |
| Eligible (net of grant) IPCEI GF costs |
- | 0 2 |
| for M&A , and Costs integration reorganization company , |
- | 0 5 |
| business divesture Marine |
0 3 |
0 7 |
| Fracking business divesture |
- | 0 2 |
| Other (tax) non-recurring provisions |
- | 1 5 |
| Other non-recurring costs |
- | 0 2 |
| Adj EBITDA |
36 4 |
39 4 |
| (%) Margin |
19 2% |
19 7% |
Starting from H1'24 De Nora, to better represent the operational profitability of the Group, decided to change its EBITDA definition, including in the EBITDA and Adj EBITDA, Accrual, Utilization and Release of Provisions for Risks and Charges, previously classified below the EBITDA. The 2023 figures have been restated accordingly.

| (€m) | FY 2024 |
Q1 2025 |
|---|---|---|
| Intangible assets |
116 0 |
111 0 |
| , plant and equipment Property |
291 8 |
293 9 |
| Equity-accounted investees |
236 8 |
236 8 |
| Fixed asset |
644 5 |
641 7 |
| Inventories | 255 5 |
259 6 |
| work of advances from Contract in net customers progress, |
36 4 |
32 7 |
| Trade receivables |
173 5 |
174 5 |
| Trade payables |
(116 8) |
(86 5) |
| working capital Operating |
348 6 |
380 3 |
| Other and liabilities current assets |
(78 2) |
(65 8) |
| working capital Net |
270 3 |
314 5 |
| Deferred tax assets |
15 5 |
16 0 |
| Other receivables and financial non-current assets |
11 4 |
13 4 |
| Employee benefits |
(25 9) |
(25 2) |
| for risks and charges Provisions |
(19 9) |
(20 3) |
| Deferred liabilities tax |
(6 0) |
(5 2) |
| Trade payables |
(0 0) |
(0 0) |
| Other payables |
(2 9) |
(3 0) |
| Other and liabilities net current asset non |
(27 8) |
(24 3) |
| invested capital Net |
887 0 |
931 9 |
| / Liquidity (Financial Indebtedness) Net current |
207 7 |
166 2 |
| Financial Indebtedness Non-current |
(140 6) |
(138 4) |
| / Liquidity (Financial Indebtedness) Net - ESMA |
67 1 |
27 8 |
| value of financial Fair instruments |
(0 3) |
0 2 |
| Liquidity / (Financial Indebtedness) Net - De Nora |
66 8 |
28 0 |
| Total Equity |
(953 8) |
(959 9) |
| Total sources |
(887 0) |
(931 9) |

| (€m) | Q1 2024 |
Q1 2025 |
|---|---|---|
| EBITDA | 35 7 |
36 0 |
| the sale of , plant and and intangible Losses equipment property assets on |
(0 0) |
(0 8) |
| Other items non-monetary |
(0 7) |
0 5 |
| Cash flows generated by before changes working capital operating activities in net |
35 0 |
35 6 |
| Change in inventory |
(14 6) |
(7 9) |
| Change trade receivables and in construction contracts |
(20 3) |
(1 5) |
| Change trade payables in |
(11 5) |
(29 0) |
| receivables/payables Change other in |
(5 9) |
(9 9) |
| Cash flows generated by changes working capital in net |
(52 2) |
(48 2) |
| Cash flows generated by operating activities |
(17 2) |
(12 6) |
| and other financial paid Net Interest Net expense |
(1 8) |
0 9 |
| paid Income taxes |
(5 4) |
(14 8) |
| cash flows generated by operating activities Net |
(24 3) |
(26 4) |
| of Sales , plant and and intangible equipment property assets |
0 4 |
1 0 |
| tangible and intangible Investments in assets1 |
(11 5) |
(12 7) |
| (Investments) financial Divestments in activities |
2 1 |
0 6 |
| cash flows used Net in investing activities |
(9 1) |
(11 0) |
| Share capital increase |
0 5 |
0 8 |
| Shares Treasury |
(22 5) |
- |
| loans/(Repayment) of loans New |
11 0 |
1 9 |
| (decrease) other financial liabilities Increase in |
(0 0) |
(0 0) |
| cash flows generated by financing Net activities |
(11 0) |
2 7 |
| (decrease) cash and cash equivalents Net increase in |
(44 4) |
(34 8) |
| cash and cash equivalents Opening |
198 5 |
215 9 |
| Exchange gains/(losses) rate |
(0 0) |
(2 0) |
| Closing cash and cash equivalents |
154 1 |
179 1 |
IR CONTACTS
[email protected] Investor Relations | Overview | De Nora
© 2025 De Nora ©Luca Campigotto
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.